肝病中的胆汁酸代谢与信号传导
本文综述胆汁酸作为信号分子调控自身代谢与转运及脂质葡萄糖稳态,并塑造肠道菌群。胆汁酸转运、代谢及信号异常参与胆汁淤积性肝病、MASLD及肝细胞癌和胆管细胞癌的发病与进展,亦影响肠道和肾脏。文章总结胆汁酸信号、代谢与转运进展,聚焦转录调控及靶向胆汁酸的新型治疗策略。
要点
- 胆汁酸作为信号分子调控自身代谢转运及脂质葡萄糖稳态。
- 胆汁酸转运、代谢及信号异常参与多种肝病发病与进展。
- 胆汁酸信号受损可影响肠道和肾脏,促进门脉高压等并发症。
核心结论
- 胆汁酸信号、代谢与转运异常参与胆汁淤积性和代谢性肝病等多种肝病发病与进展。
研究设计与样本
- 综述,总结胆汁酸信号、代谢与转运的最新进展,聚焦转录调控及靶向胆汁酸的新型治疗策略。
主要发现
- 胆汁酸调控自身代谢和转运以及脂质和葡萄糖稳态的关键方面。
- 胆汁酸塑造肠道菌群,同时被微生物群代谢。
- 胆汁酸转运、代谢和生理信号功能紊乱参与胆汁淤积性疾病和MASLD以及肝细胞癌和胆管细胞癌的发病与进展。
- 胆汁酸信号受损可影响肠道和肾脏,促进肠道完整性衰竭并驱动门脉高压进展和并发症、胆汁性肾病及结直肠癌等肝外恶性肿瘤的发生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bile acids (BAs) serve as signalling molecules, efficiently regulating their own metabolism and transport, as well as key aspects of lipid and glucose homeostasis. BAs shape the gut microbial flora and conversely are metabolised by microbiota. Disruption of BA transport, metabolism and physiological signalling functions contribute to the pathogenesis and progression of a wide range of liver diseases including cholestatic disorders and MASLD (metabolic dysfunction-associated steatotic liver disease), as well as hepatocellular and cholangiocellular carcinoma. Additionally, impaired BA signalling may also affect the intestine and kidney, thereby contributing to failure of gut integrity and driving the progression and complications of portal hypertension, cholemic nephropathy and the development of extrahepatic malignancies such as colorectal cancer. In this review, we will summarise recent advances in the understanding of BA signalling, metabolism and transport, focusing on transcriptional regulation and novel BA-focused therapeutic strategies for cholestatic and metabolic liver diseases.
引用
- Fuchs CD, Simbrunner B, Baumgartner M, et al. Bile acid metabolism and signalling in liver disease. J Hepatol. 2024. PMID: 39349254. doi:10.1016/j.jhep.2024.09.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。